checkAd
    Startseite > Aktien > Apollomics > Nachrichten
    Apollomics Aktie
    0,4059
     
    USD
    +0,89 %
    +0,0036 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,4050
     
    USD
    300 STK
    Geldkurs 08.05.24
    0,4132
     
    USD
    200 STK
    Briefkurs 08.05.24
    ISIN: KYG0411D1079 · WKN: A3D455 · SYM: APLM · Kaiman-Inseln

    Neueste Nachrichten

    Apollomics Announces Private Placement Financing and Addition to Board of Directors
    08.05.24 · globenewswire · Apollomics
    Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
    25.04.24 · globenewswire · Apollomics
    Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    10.04.24 · globenewswire · Apollomics
    Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    02.04.24 · globenewswire · Apollomics
    Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
    28.03.24 · globenewswire · Apollomics
    Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024
    26.03.24 · globenewswire · Apollomics
    Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
    04.03.24 · globenewswire · Apollomics
    Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    07.02.24 · globenewswire · Apollomics
    Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
    19.01.24 · globenewswire · Apollomics
    Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
    17.01.24 · globenewswire · Apollomics
    Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
    03.01.24 · globenewswire · Apollomics
    Apollomics to Present at the 2024 Biotech Showcase
    02.01.24 · globenewswire · Apollomics